-
How Can We Cure America's Excessive Drug-Price Problem?
08 Jun 2019 08:00 GMT
… no question that the pharmaceutical industry is among … the clinical trial process and the FDA approval process. … Character.
Brokamp: Drug.
Southwick: It's a treatment for hyperthyroidism … prescribed the wrong drug, because the doctor chose a drug with a …
-
Korean hypertension drugs gear up for bigger sales in 2019
03 Mar 2019 08:06 GMT
… treatments.
The biggest competitor is Boryung Pharmaceutical’s Kanarb, a new hypertension drug … .
Daewoong currently sells co-promotional drugs Olmetec, Olmetec Plus, Sevikar, Sevikar HC, as …
-
Notice Regarding Manufacture and Sales Approval of 6 Ingredients/ 15 Products of Generic Drugs for KYOSOMIRAI PHARMA
23 Aug 2017 03:43 GMT
… / 40mg
"KYOSOMIRAI"
Olmetec Tablets(UK)/
Benicar Tablets … sales business of prescription pharmaceuticals centered on generic drugs as well as … high value added prescription pharmaceuticals mainly for generic drugs.
【Outline of KYOSOMIRAI …
-
Pasqua Hospital's Medical Surveillance Unit a lifesaver for Regina man
25 Jul 2017 04:26 GMT
… the Pasqua Hospital's Medical Surveillance Unit (MSU) for … Butch Stokes received at the Medical Surveillance Unit at the … , doctors determined Butch had a rare reaction to Olmetec — a drug he … written up in the Canadian Medical Journal,” Linda said.
Butch …
-
Sandoz Canada launches Sandoz Olmesartan for the treatment of high blood pressure
02 May 2017 13:08 GMT
… generic version of OLMETEC*, for the treatment of mild to moderate … to a class of medications called angiotensin II receptor … development, including unexpected clinical trial results and additional analysis … largest producer of generic drugs. A leader in its …
-
Daiichi Sankyo : Value Report 2023 (10.1MB)
31 Oct 2023 09:37 GMT
… platform ・Protein engineering, medicinal chemistry
・Pharmacological efficacy, … to innovative pharmaceuticals that offer new treatment options, … from Enhertu clinical trials, and product sales … delivering new drugs
Accumulated pharmaceutical information
Research …
-
Daiichi Sankyo Company's (DSKYF) Management on Q1 2018 Results - Earnings Call Transcript
05 Aug 2017 22:21 GMT
… treatment, Daiichi Sankyo Espha products expanded sales. On the contrary, Olmetec … as unapproved drugs and indications with high medical needs in … We reached agreement with FDA on Special Protocol Assessment … carry on the quizartinib trial. Top line results will …
-
Angiotensin II receptor blockers: What are they?
23 May 2023 10:51 GMT
… :
Additionally, the medications are a common alternative treatment for people who … (Teveten)
candesartan (Amias)
olmesartan (Olmetec)
telmisartan (Micardis)
valsartan (Diovan)
losartan … mg) for each drug:
In some cases, doctors may not recommend ARBs …
-
Daiichi Sankyo Co Ltd (DSKYF) CEO Sunao Manabe on Q4 2020 Results - Earnings Call Transcript
30 Apr 2020 14:43 GMT
… continued supply of pharmaceutical products and implementing disaster … are implementing clinical trials in collaboration with … for anti-hypertensive agent, Olmetec; anti-inflammatory analgesic, … medical needs. About 80% of the patients under statin treatment …